Evolent Health

Traded on the St. Petersburg Stock Exchange
Evolent Health, Inc. is engaged in healthcare delivery and payment.
Evolent Health stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Evolent Health balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Evolent Health cash flows

Report period2018 2019 2020 2021 2022 Q2 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Evolent Health multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Evolent Health profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Evolent Health assets
Evolent Health cash flows

Evolent Health shares

TickerNameTypeNominal valueISINPrice
EVH:USEvolent Health, Inc.Common share-US30050B1017$32.42
Evolent Health news
29.06.2022
Evolent Health is acquiring IPG, a provider of musculoskeletal surgical solutions. Evolent Health will pay $375 million in cash and an additional $87 million based on IPG's future performance. The deal is scheduled to close in Q3 2022.
Source: {source} pictogram ir.evolenthealth.com
Pictogram next
05.05.2022
Evolent Health's GAAP loss for the 3 months of 2022 was $5.35 million, down 45.4% from $9.807 million in the prior year. Revenue increased 38.1% to $297.057 million from $215.071 million a year earlier.
Source: {source} pictogram ir.evolenthealth.com
Pictogram next
24.02.2022
Evolent Health's GAAP loss for 2021 was $37.601 million, down 8.8 times from $334.246 million in the previous year. Revenue fell 1.8% to $907.957 million from $924.639 million a year earlier.
Source: {source} pictogram ir.evolenthealth.com
Pictogram next
04.11.2021
Evolent Health's GAAP loss for 9M 2021 was $31.954m, down 10 times from $320.443m in the previous year. Revenues decreased 2.7% to $659.599m from $678.103m a year earlier.
Source: {source} pictogram ir.evolenthealth.com
Pictogram next
All Evolent Health news
General information
Company nameEvolent Health
SectorInformation Technology / Software & Services / Software / Application Software
Business address800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Mailing address800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Websitewww.evolenthealth.com
Information disclosurewww.sec.gov